1. Home
  2. VVI vs YMAB Comparison

VVI vs YMAB Comparison

Compare VVI & YMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVI
  • YMAB
  • Stock Information
  • Founded
  • VVI 1926
  • YMAB 2015
  • Country
  • VVI United States
  • YMAB United States
  • Employees
  • VVI N/A
  • YMAB N/A
  • Industry
  • VVI Business Services
  • YMAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • VVI Consumer Discretionary
  • YMAB Health Care
  • Exchange
  • VVI Nasdaq
  • YMAB Nasdaq
  • Market Cap
  • VVI 735.5M
  • YMAB 631.1M
  • IPO Year
  • VVI N/A
  • YMAB 2018
  • Fundamental
  • Price
  • VVI $44.61
  • YMAB $11.14
  • Analyst Decision
  • VVI Strong Buy
  • YMAB Strong Buy
  • Analyst Count
  • VVI 2
  • YMAB 8
  • Target Price
  • VVI $48.00
  • YMAB $21.38
  • AVG Volume (30 Days)
  • VVI 242.0K
  • YMAB 268.9K
  • Earning Date
  • VVI 11-07-2024
  • YMAB 11-08-2024
  • Dividend Yield
  • VVI N/A
  • YMAB N/A
  • EPS Growth
  • VVI 58.18
  • YMAB N/A
  • EPS
  • VVI 1.06
  • YMAB N/A
  • Revenue
  • VVI $1,399,418,000.00
  • YMAB $84,553,000.00
  • Revenue This Year
  • VVI $10.60
  • YMAB $10.24
  • Revenue Next Year
  • VVI $1.39
  • YMAB $20.21
  • P/E Ratio
  • VVI $43.65
  • YMAB N/A
  • Revenue Growth
  • VVI 17.10
  • YMAB N/A
  • 52 Week Low
  • VVI $29.46
  • YMAB $5.17
  • 52 Week High
  • VVI $47.49
  • YMAB $20.90
  • Technical
  • Relative Strength Index (RSI)
  • VVI 64.55
  • YMAB 25.01
  • Support Level
  • VVI $42.97
  • YMAB $12.47
  • Resistance Level
  • VVI $45.92
  • YMAB $15.69
  • Average True Range (ATR)
  • VVI 1.69
  • YMAB 0.97
  • MACD
  • VVI 0.36
  • YMAB -0.46
  • Stochastic Oscillator
  • VVI 72.47
  • YMAB 9.88

About VVI Viad Corp

Viad Corp is a marketing company engaged in providing extraordinary experiences, including hospitality and leisure activities, experiential marketing, and live events. The company has three segments; Pursuit includes a collection of inspiring and unforgettable travel experiences that includes recreational attractions, hotels and lodges, food and beverage, retail, sightseeing, and ground transportation services, Spiro includes a marketing agency that partners with brands around the world to manage and elevate their experiential marketing activities, and GES Exhibitions is an exhibition services company that partners with exhibition and conference organizers as a full-service provider of strategic and logistics solutions to manage the complexity of their shows.

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

Share on Social Networks: